Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03445104 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise
A Early Phase 1 study of Cognitive Enhancement During Exercise, sponsored by St. Louis University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT03445104 is a Early Phase 1 study of Cognitive Enhancement During Exercise that has completed, run by St. Louis University. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03445104, a Early Phase 1 study of Cognitive Enhancement During Exercise, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effects of acute huperzine A ingestion prior to exercise on cognitive function and perceived effort in exercise-trained individuals. Huperzine A has shown the ability to improve cognitive function in dementia patients, and is currently marketed as a cognitive enhancing supplement. Study participants will receive either huperzine A or placebo during the first experimental session, and will receive the other substance during the second session.
Conditions Studied
Interventions
- OTHER Placebo
- OTHER Huperzine A
Study Locations (1)
Missouri
- Allied Health Professional Building - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-01-16 |
| Est. Completion | 2018-04-05 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03445104
The ClinicalTrials.gov registry entry for NCT03445104 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cognitive Enhancement During Exercise appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03445104 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT03445104 about?
NCT03445104 is a clinical study titled "Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise". This study evaluates the effects of acute huperzine A ingestion prior to exercise on cognitive function and perceived effort in exercise-trained individuals. Huperzine A has shown the ability to improve cognitive function in dementia patients, and is currently marketed as a cognitive enhancing suppl...
What is the current status of trial NCT03445104?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2018-01-16. Estimated completion is 2018-04-05.
What conditions does trial NCT03445104 study?
This clinical trial studies the following conditions: Cognitive Enhancement During Exercise.
What interventions are being tested in trial NCT03445104?
The interventions under investigation include: Placebo (OTHER), Huperzine A (OTHER).
Who is sponsoring clinical trial NCT03445104?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03445104 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.